+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Pancreas - Medical Devices Pipeline Assessment, 2019

  • ID: 4829228
  • Report
  • July 2019
  • Region: Global
  • 151 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Admetsys Corp
  • Cerco Medical LLC
  • Defymed SAS
  • Imperial College London
  • Medtronic Diabetes
  • Tandem Diabetes Care Inc
  • MORE
Artificial Pancreas - Medical Devices Pipeline Assessment, 2019

Summary

The author's Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Assessment, 2019" provides an overview of Artificial Pancreas currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the author's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Artificial Pancreas under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Pancreas under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Admetsys Corp
  • Cerco Medical LLC
  • Defymed SAS
  • Imperial College London
  • Medtronic Diabetes
  • Tandem Diabetes Care Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Artificial Pancreas Overview

3 Products under Development
3.1 Artificial Pancreas - Pipeline Products by Stage of Development
3.2 Artificial Pancreas - Pipeline Products by Territory
3.3 Artificial Pancreas - Pipeline Products by Regulatory Path
3.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date
3.5 Artificial Pancreas - Ongoing Clinical Trials

4 Artificial Pancreas - Pipeline Products under Development by Companies
4.1 Artificial Pancreas Companies - Pipeline Products by Stage of Development
4.2 Artificial Pancreas - Pipeline Products by Stage of Development

5 Artificial Pancreas Companies and Product Overview
5.1 Admetsys Corp Company Overview
5.2 Advanced Biosensors-Ohio LLC (Inactive) Company Overview
5.3 Beta Bionics Inc Company Overview
5.4 Beta-O2 Technologies Ltd Company Overview
5.5 Bigfoot Biomedical Inc Company Overview
5.6 BioTex Inc Company Overview
5.7 Cerco Medical LLC Company Overview
5.8 Converge Biotech, Inc. Company Overview
5.9 Covalor Medical, LLC Company Overview
5.10 De Montfort University Company Overview
5.11 Debiotech SA Company Overview
5.12 Defymed SAS Company Overview
5.13 Diabeloop Company Overview
5.14 EOFlow Co Ltd Company Overview
5.15 Giner Inc Company Overview
5.16 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview
5.17 Healios Inc Company Overview
5.18 Imperial College London Company Overview
5.19 Inreda Diabetic BV Company Overview
5.20 Insulet Corp Company Overview
5.21 Kencak LLC Company Overview
5.22 Medicsensors SL Company Overview
5.23 Medtronic Diabetes Company Overview
5.24 Miromatrix Medical Inc Company Overview
5.25 Pacific Diabetes Technologies, Inc. Company Overview
5.26 Pancreum, LLC Company Overview
5.27 PharmaCyte Biotech Inc Company Overview
5.28 Polytechnic University of Valencia Company Overview
5.29 Rensselaer Polytechnic Institute Company Overview
5.30 Senseonics Holdings Inc Company Overview
5.31 Tandem Diabetes Care Inc Company Overview
5.32 TecMed Inc Company Overview
5.33 The Alfred Mann Foundation Company Overview
5.34 TypeZero Technologies LLC Company Overview
5.35 Universidad Autonoma de Madrid Company Overview
5.36 University of California San Francisco Company Overview
5.37 University of California Santa Barbara Company Overview
5.38 University of Cambridge Company Overview
5.39 University of Florida Company Overview
5.40 University of Newcastle Company Overview
5.41 XERIS Pharmaceuticals Inc Company Overview
5.42 Yale University Company Overview

6 Artificial Pancreas - Recent Developments
6.1 Jun 09, 2019: Tandem Diabetes Care reports positive results from two studies of the t:slim X2 Insulin Pump With Control-IQ Technology
6.2 Jun 09, 2019: Insulet’s Omnipod Horizon Hybrid Closed-Loop System improves Glycemic Control in patients as young as two years Old with Type 1 Diabetes
6.3 Jun 08, 2019: Medtronic initiates pivotal trial for Bluetooth enabled MiniMed 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing
6.4 Jun 08, 2019: The iLet Bionic Pancreas Increased Time in Range for Adults with Type 1 Diabetes
6.5 Jun 07, 2019: Beta Bionics reports positive data from iLet Bionic Pancreas' study
6.6 Jun 07, 2019: Tandem Diabetes Care announces Conference Call Following Data Presentations at the ADA Scientific Sessions
6.7 Jun 06, 2019: Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet bionic pancreas using dasiglucagon
6.8 Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency
6.9 May 28, 2019: MiniMed 670G System Real-World Data on 8 Million patient days shows 71 percent time in range across all age groups
6.10 May 23, 2019: Beta Bionics starts clinical trial of iLet bionic pancreas
6.11 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
6.12 May 15, 2019: Publication in - The Lancet Digital Health of the positive results of the WP7 clinical trial with Diabeloop's integrated DBLG1 device in real life
6.13 May 09, 2019: New study demonstrates safety and effectiveness of the MiniMed 640G System reducing hypoglycemia compared with insulin pump therapy without CGM in type 1 diabetes
6.14 May 09, 2019: Xeris Pharmaceuticals announces first quarter 2019 financial results and highlights its pipeline
6.15 May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
6.16 May 02, 2019: Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year

7 Appendix
7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Artificial Pancreas - Pipeline Products by Stage of Development
Table 2: Artificial Pancreas - Pipeline Products by Territory
Table 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Table 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Table 5: Artificial Pancreas - Ongoing Clinical Trials
Table 6: Artificial Pancreas Companies - Pipeline Products by Stage of Development
Table 7: Artificial Pancreas - Pipeline Products by Stage of Development
Table 8: Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Admetsys Smart Pancreas - Product Status
Table 10: Admetsys Smart Pancreas - Product Description
Table 11: Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Artificial Pancreas - Product Status
Table 13: Artificial Pancreas - Product Description
Table 14: Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: iLet - Bi-harmonal Closed loop System - Product Status
Table 16: iLet - Bi-harmonal Closed loop System - Product Description
Table 17: iLet Bionic Pancreas - Glucagon Version - Product Status
Table 18: iLet Bionic Pancreas - Glucagon Version - Product Description
Table 19: iLet Bionic Pancreas - Insulin-only Version - Product Status
Table 20: iLet Bionic Pancreas - Insulin-only Version - Product Description
Table 21: Beta Bionics Inc - Ongoing Clinical Trials Overview
Table 22: iLet - Bi-harmonal Closed loop System - Bihormonal Bionic Pancreas for the Treatment of Diabetes Post-Pancreatectomy in Children With Congenital Hyperinsulinism - A Pilot Study
Table 23: iLet - Bi-harmonal Closed loop System - Feasibility of Outpatient Automated Blood Glucose Control with the Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
Table 24: iLet Bionic Pancreas - Insulin-only Version - Individualizing Automated Closed Loop Glucose Control through Pharmacokinetic Profiling in an Insulin-only Bionic Pancreas
Table 25: iLet Bionic Pancreas - Insulin-only Version - The Set-point Study for Type 2 Diabetes: Evaluating the Safety and Efficacy of an Insulin only Bionic Pancreas System in Patients with Type 2 Diabetes
Table 26: Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 27: ßAir Bio-artificial Pancreas - Product Status
Table 28: ßAir Bio-artificial Pancreas - Product Description
Table 29: Beta-O2 Technologies Ltd - Ongoing Clinical Trials Overview
Table 30: ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-air in Patients with Type 1 Diabetes Mellitus
Table 31: Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Bigfoot smartloop System - Product Status
Table 33: Bigfoot smartloop System - Product Description
Table 34: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Artificial Pancreas - Product Status
Table 36: Artificial Pancreas - Product Description
Table 37: Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Islet Sheet - Product Status
Table 39: Islet Sheet - Product Description
Table 40: Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Bioartificial Pancreas System - Product Status
Table 42: Bioartificial Pancreas System - Product Description
Table 43: Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Artificial Pancreas - Product Status
Table 45: Artificial Pancreas - Product Description
Table 46: De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: InSmart Artificial Pancreas - Product Status
Table 48: InSmart Artificial Pancreas - Product Description
Table 49: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Next Generation Artificial Pancreas - Product Status

List of Figures
Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development
Figure 2: Artificial Pancreas - Pipeline Products by Territory
Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path
Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
Figure 5: Artificial Pancreas - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Admetsys Corp
  • Advanced Biosensors-Ohio LLC
  • Beta Bionics Inc
  • Beta-O2 Technologies Ltd
  • Bigfoot Biomedical Inc
  • BioTex Inc
  • Cerco Medical LLC
  • Converge Biotech, Inc.
  • Covalor Medical, LLC
  • De Montfort University
  • Debiotech SA
  • Defymed SAS
  • Diabeloop
  • EOFlow Co Ltd
  • Giner Inc
  • Harvard John A Paulson School of Engineering and Applied Sciences
  • Healios Inc
  • Imperial College London
  • Inreda Diabetic BV
  • Insulet Corp
  • Kencak LLC
  • Medicsensors SL
  • Medtronic Diabetes
  • Miromatrix Medical Inc
  • Pacific Diabetes Technologies, Inc.
  • Pancreum, LLC
  • PharmaCyte Biotech Inc
  • Polytechnic University of Valencia
  • Rensselaer Polytechnic Institute
  • Senseonics Holdings Inc
  • Tandem Diabetes Care Inc
  • TecMed Inc
  • The Alfred Mann Foundation
  • TypeZero Technologies LLC
  • Universidad Autonoma de Madrid
  • University of California San Francisco
  • University of California Santa Barbara
  • University of Cambridge
  • University of Florida
  • University of Newcastle
  • XERIS Pharmaceuticals Inc
  • Yale University
Note: Product cover images may vary from those shown
Adroll
adroll